Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT04338360 Approved for marketing - COVID19 Clinical Trials

Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19

Start date: n/a
Study type: Expanded Access

This expanded access program will provide access to investigational convalescent plasma for patients in acute care facilities infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.